Citi lifts Exide target on lithium-ion prospects; Kotak flags margin and return-ratio risks

Citi raised its Exide Industries target price to ₹510 from ₹410, citing resilient automotive and industrial demand and approaching lithium-ion cell commercialization. Kotak raised its target to ₹325 from ₹300 but retained a sell call, pointing to heavy capex, limited pricing power and technology dependence.

— Source publishedTue, 4 Aug, 2026, 08:52 IST·First seen Tue, 4 Aug, 2026, 09:16 IST·Source NDTV Profit

What happened

Exide Industries · Citi raised Exide’s target price on strong automotive and industrial demand and upcoming lithium-ion cell commercialization. Kotak retained

Key facts

  • Q1FY27
  • Citi target price ₹510, raised from ₹410
  • Kotak target price ₹325, raised from ₹300

Why this matters

Exide’s battery transition raises the strategic value of technology partnerships, supply-chain control and adjacent energy-storage capabilities, while reducing dependence on externally sourced cell know-how.

What to watch

  • Formal start of commercial lithium-ion cell production and stated utilization ramp.
  • Binding offtake agreements or OEM qualifications for domestically manufactured cells.
  • Capex overruns, additional equity/debt funding requirements or a material rise in net debt.
  • Sustained deterioration in EBITDA margin, ROCE or free cash flow from battery operations.
  • Government incentives, import-duty changes or PLI-related developments affecting domestic cell economics.
  • Lead-price movements and evidence of reduced pricing power in automotive replacement batteries.
  • Track commissioning milestones, trial production and commercial launch timelines at Exide Energy Solutions.
  • Watch announced customer tie-ups or supply agreements with EV OEMs, fleet operators, telecom providers and energy-storage integrators.
  • Monitor quarterly capex, debt, operating cash flow, depreciation and return-on-capital trends.
  • Assess whether lead-acid battery price increases offset lead-price volatility and protect core-business margins.
  • Compare Exide's cell cost, chemistry roadmap and localization progress with Amara Raja, Tata-backed cell projects and imported Chinese/Korean alternatives.